Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 636785, 13 pages
http://dx.doi.org/10.1155/2013/636785
Research Article

Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients

1Hedmark University College, 2306 Hamar, Norway
2Department of Chemistry, Biotechnology and Food Science, Norwegian University for Life Sciences, 1432 Ås, Norway
3Department of Gastroenterology, Akershus University Hospital, 1478 Lørenskog, Norway
4Department of Clinical Molecular Biology and Laboratory Sciences (EpiGen), Division of Medicine, Akershus University Hospital, University of Oslo, 0316 Oslo, Norway
5Pediatric Department, Oslo University Hospital, Ullevål, 0450 Oslo, Norway
6Medical Clinic, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway

Received 30 April 2013; Revised 15 August 2013; Accepted 29 August 2013

Academic Editor: Akira Andoh

Copyright © 2013 Lill Therese Thorkildsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. V. Hooper, D. R. Littman, and A. J. Macpherson, “Interactions between the microbiota and the immune system,” Science, vol. 336, pp. 1268–1273, 2012. View at Google Scholar
  2. J. L. Round and S. K. Mazmanian, “The gut microbiota shapes intestinal immune responses during health and disease,” Nature Reviews Immunology, vol. 9, no. 5, pp. 313–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Shanahan and C. N. Bernstein, “The evolving epidemiology of inflammatory bowel disease,” Current Opinion in Gastroenterology, vol. 25, no. 4, pp. 301–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Giongo, K. A. Gano, D. B. Crabb et al., “Toward defining the autoimmune microbiome for type 1 diabetes,” ISME Journal, vol. 5, no. 1, pp. 82–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, “Microbial ecology: human gut microbes associated with obesity,” Nature, vol. 444, no. 7122, pp. 1022–1023, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Penders, C. Thijs, P. A. Van Den Brandt et al., “Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study,” Gut, vol. 56, no. 5, pp. 661–667, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. N. Frank, A. L. St. Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace, “Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13780–13785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Xavier and D. K. Podolsky, “Unravelling the pathogenesis of inflammatory bowel disease,” Nature, vol. 448, no. 7152, pp. 427–434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. R. B. Sartor, “Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis,” Nature Clinical Practice Gastroenterology and Hepatology, vol. 3, no. 7, pp. 390–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Braun and B. Wei, “Body traffic: ecology, genetics, and immunity in inflammatory bowel disease,” Annual Review of Pathology, vol. 2, pp. 401–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. B. Sartor, “Key questions to guide a better understanding of host-commensal microbiota interactions in intestinal inflammation,” Mucosal Immunology, vol. 4, no. 2, pp. 127–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Bouma and W. Strober, “The immunological and genetic basis of inflammatory bowel disease,” Nature Reviews Immunology, vol. 3, no. 7, pp. 521–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. P. Tamboli, C. Neut, P. Desreumaux, and J. F. Colombel, “Dysbiosis in inflammatory bowel disease,” Gut, vol. 53, no. 1, pp. 1–4, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Ewaschuk, Q. Z. Tejpar, I. Soo, K. L. Madsen, and R. N. Fedorak, “The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease,” Current Gastroenterology Reports, vol. 8, no. 6, pp. 486–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Rutgeerts, K. Goboes, M. Peeters et al., “Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum,” Lancet, vol. 338, no. 8770, pp. 771–774, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Hansen, R. K. Russell, C. Reiff et al., “Microbiota of De-Novo Pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis,” American Journal of Gastroenterology, vol. 107, pp. 1913–1922, 2012. View at Google Scholar
  17. M. Sekelja, I. Rud, S. H. Knutsen et al., “Abrupt temporal fluctuations in chicken fecal microbiota explained by gastrointestinal origin,” Applied and Environmental Microbiology, 2012. View at Google Scholar
  18. M. Zimonja, K. Rudi, P. Trosvik, and T. Næs, “Multivariate curve resolution of mixed bacterial DNA sequence spectra: identification and quantification of bacteria in undefined mixture samples,” Journal of Chemometrics, vol. 22, no. 5, pp. 309–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. C. Vebø, M. Sekelja, R. Nestestog et al., “Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant array,” Clinical and Vaccine Immunology, vol. 18, no. 8, pp. 1326–1335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. E. Lennard-Jones, “Classification of inflammatory bowel disease,” Scandinavian Journal of Gastroenterology, vol. 24, no. 170, pp. 2–6, 1989. View at Google Scholar · View at Scopus
  21. C. Gasche, J. Scholmerich, J. Brynskov et al., “A simple classification of Crohn's disease: report of the working party for the world congresses of gastroenterology, Vienna 1998,” Inflammatory Bowel Diseases, vol. 6, no. 1, pp. 8–15, 2000. View at Google Scholar · View at Scopus
  22. P. Ricanek, S. Brackmann, G. Perminow et al., “Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers,” Scandinavian Journal of Gastroenterology, vol. 46, no. 9, pp. 1081–1091, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. B. J. Haas, D. Gevers, A. M. Earl et al., “Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons,” Genome Research, vol. 21, no. 3, pp. 494–504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Rudi, M. Zimonja, and T. Næs, “Alignment-independent bilinear multivariate modelling (AIBIMM) for global analyses of 16S rRNA gene phylogeny,” International Journal of Systematic and Evolutionary Microbiology, vol. 56, no. 7, pp. 1565–1575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. H. Giaffer, C. D. Holdsworth, and B. I. Duerden, “The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique,” Journal of Medical Microbiology, vol. 35, no. 4, pp. 238–243, 1991. View at Google Scholar · View at Scopus
  26. P. Seksik, L. Rigottier-Gois, G. Gramet et al., “Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon,” Gut, vol. 52, no. 2, pp. 237–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Mondot, S. Kang, J. P. Furet et al., “Highlighting new phylogenetic specificities of Crohn's disease microbiota,” Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 185–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Lepage, P. Seksik, M. Sutren et al., “Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD,” Inflammatory Bowel Diseases, vol. 11, no. 5, pp. 473–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. G. Zoetendal, A. Von Wright, T. Vilpponen-Salmela, K. Ben-Amor, A. D. L. Akkermans, and W. M. De Vos, “Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces,” Applied and Environmental Microbiology, vol. 68, no. 7, pp. 3401–3407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. U. Gophna, K. Sommerfeld, S. Gophna, W. F. Doolittle, and S. J. O. Veldhuyzen Van Zanten, “Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis,” Journal of Clinical Microbiology, vol. 44, no. 11, pp. 4136–4141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. W. Walker, J. D. Sanderson, C. Churcher et al., “High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease,” BMC Microbiology, vol. 11, article 7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Baumgart, B. Dogan, M. Rishniw et al., “Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum,” ISME Journal, vol. 1, no. 5, pp. 403–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Boudeau, A.-L. Glasser, E. Masseret, B. Joly, and A. Darfeuille-Michaud, “Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease,” Infection and Immunity, vol. 67, no. 9, pp. 4499–4509, 1999. View at Google Scholar · View at Scopus
  34. N. Rolhion and A. Darfeuille-Michaud, “Adherent-invasive Escherichia coli in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 13, no. 10, pp. 1277–1283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Darfeuille-Michaud, J. Boudeau, P. Bulois et al., “High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease,” Gastroenterology, vol. 127, no. 2, pp. 412–421, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Sepehri, E. Khafipour, C. N. Bernstein et al., “Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 17, no. 7, pp. 1451–1463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Lapaquette, A.-L. Glasser, A. Huett, R. J. Xavier, and A. Darfeuille-Michaud, “Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly,” Cellular Microbiology, vol. 12, no. 1, pp. 99–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Meconi, A. Vercellone, F. Levillain et al., “Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro,” Cellular Microbiology, vol. 9, no. 5, pp. 1252–1261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Manichanh, L. Rigottier-Gois, E. Bonnaud et al., “Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach,” Gut, vol. 55, no. 2, pp. 205–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Sokol, P. Seksik, J. P. Furet et al., “Low counts of Faecalibacterium prausnitzii in colitis microbiota,” Inflammatory Bowel Diseases, vol. 15, no. 8, pp. 1183–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-P. Segain, J.-P. Galmiche, D. Raingeard De La Blétière et al., “Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease,” Gut, vol. 47, no. 3, pp. 397–403, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Fava and S. Danese, “Intestinal microbiota in inflammatory bowel disease: friend of foe?” World Journal of Gastroenterology, vol. 17, no. 5, pp. 557–566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. S. H. Duncan, P. Louis, and H. J. Flint, “Cultivable bacterial diversity from the human colon,” Letters in Applied Microbiology, vol. 44, no. 4, pp. 343–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Sokol, B. Pigneur, L. Watterlot et al., “Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 43, pp. 16731–16736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Joossens, G. Huys, M. Cnockaert et al., “Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives,” Gut, vol. 60, no. 5, pp. 631–637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. B. P. Willing, J. Dicksved, J. Halfvarson et al., “A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes,” Gastroenterology, vol. 139, no. 6, pp. 1844–1854, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Rajilić-Stojanović, H. Smidt, and W. M. De Vos, “Diversity of the human gastrointestinal tract microbiota revisited,” Environmental Microbiology, vol. 9, no. 9, pp. 2125–2136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. M. Bloom, V. N. Bijanki, G. M. Nava et al., “Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease,” Cell Host and Microbe, vol. 9, no. 5, pp. 390–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Andoh, H. Kuzuoka, T. Tsujikawa et al., “Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease,” Journal of Gastroenterology, vol. 47, pp. 1298–1307, 2012. View at Google Scholar
  50. A. Andoh, H. Imaeda, T. Aomatsu et al., “Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis,” Journal of Gastroenterology, vol. 46, no. 4, pp. 479–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. P. B. Eckburg, E. M. Bik, C. N. Bernstein et al., “Microbiology: diversity of the human intestinal microbial flora,” Science, vol. 308, no. 5728, pp. 1635–1638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. G. C. Parkes, N. B. Rayment, B. N. Hudspith et al., “Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 24, no. 1, pp. 31–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Tana, Y. Umesaki, A. Imaoka, T. Handa, M. Kanazawa, and S. Fukudo, “Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 22, no. 5, p. 512-e115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Schoepfer, M. Trummler, P. Seeholzer, B. Seibold-Schmid, and F. Seibold, “Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies,” Inflammatory Bowel Diseases, vol. 14, no. 1, pp. 32–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Chassaing and A. Darfeuillemichaud, “The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases,” Gastroenterology, vol. 140, no. 6, pp. 1720–1728, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Stecher, R. Robbiani, A. W. Walker et al., “Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota,” PLoS Biology, vol. 5, no. 10, pp. 2177–2189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Lupp, M. L. Robertson, M. E. Wickham et al., “Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae,” Cell Host and Microbe, vol. 2, no. 2, pp. 119–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. L. A. G. Rodríguez, A. Ruigómez, and J. Panés, “Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease,” Gastroenterology, vol. 130, no. 6, pp. 1588–1594, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. D. N. Frank, C. E. Robertson, C. M. Hamm et al., “Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases,” Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 179–184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Seksik, P. Lepage, M.-F. De La Cochetière et al., “Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA,” Journal of Clinical Microbiology, vol. 43, no. 9, pp. 4654–4658, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Zhang, B. Liu, Y. Zhang, H. Wei, Y. Lei, and L. Zhao, “Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis,” Journal of Clinical Microbiology, vol. 45, no. 2, pp. 496–500, 2007. View at Publisher · View at Google Scholar · View at Scopus